Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved
Needle and syringe exchanges need to adapt to meet the needs of people who inject steroids and image-enhancing drugs
Newest MDR-TB drug prices could fall by up to 95% through generic production
TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis
Three-month isoniazid/pyrazinamide regimen prevents TB as well as 6-month isoniazid in people living with HIV
Can Europe reach the 90-90-90 target for HIV treatment by 2020?
Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis
Why is injecting equipment re-used? Drug users do their own research to find out
Peer workers improve drug users’ engagement with HIV care in Ukraine
